There is no single “best” anxiety medication for everyone, but SSRIs and SNRIs are the most widely recommended starting point. These two drug classes are the first-line treatment for generalized anxiety disorder, social anxiety disorder, and panic disorder, backed by decades of clinical evidence. The right choice depends on your specific symptoms, how you respond to treatment, and what side effects you’re willing to tolerate.
SSRIs and SNRIs: The Standard Starting Point
SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors) work by adjusting the balance of chemical messengers in your brain that regulate mood and stress responses. Common SSRIs prescribed for anxiety include sertraline, escitalopram, paroxetine, and fluoxetine. The most commonly prescribed SNRIs are venlafaxine and duloxetine.
A large meta-analysis of 122 trials with nearly 16,000 patients found that SSRIs and SNRIs both produce significant improvement in anxiety compared to placebo. By the eighth week of treatment, there was no meaningful difference in effectiveness between the two classes. That’s an important detail: your prescriber often chooses between them based on side effect profiles and your other health needs rather than because one class works dramatically better than the other.
The biggest practical downside is the wait. SSRIs generally take one to four weeks before you notice any benefit, with full effects building over 8 to 12 weeks. SNRIs typically take six to eight weeks for noticeable relief. That waiting period can feel long when you’re struggling, and it’s one of the most common reasons people abandon treatment too early.
Side Effects That Influence the Choice
The product labels for SSRIs list sexual side effects at under 15%, but real-world data tells a different story. When patients are asked directly, between 30% and 60% of people on SSRIs report some form of sexual dysfunction, including reduced desire, difficulty with arousal, or trouble reaching orgasm. Among individual medications, paroxetine tends to cause the highest rates (around 43%), while other SSRIs range from 7% to 30% in younger adults.
Weight gain is the other concern that comes up frequently. About 5% to 10% of people on antidepressants gain a significant amount of weight (7% or more of their body weight). Here again, paroxetine stands out: in one study, 25.5% of paroxetine users gained that much weight, compared to just 4.2% on sertraline and 6.8% on fluoxetine. Fluoxetine actually showed a slight average weight decrease. These differences matter, and they’re worth discussing with your prescriber before starting treatment.
SNRIs share many of the same side effects but can also raise blood pressure slightly, which makes them a less ideal fit for some people. On the other hand, SNRIs may be preferred if you also have chronic pain, since they act on an additional chemical pathway that helps with pain signaling.
Benzodiazepines: Fast but Risky
Benzodiazepines like alprazolam, lorazepam, and clonazepam work faster than any other class of anxiety medication. They produce noticeable relief within the first week, and during the first four weeks of treatment they outperform both SSRIs and SNRIs. That speed is appealing, but it comes with serious trade-offs.
By week eight, benzodiazepines are no more effective than SSRIs or SNRIs for most anxiety disorders. Meanwhile, the risks accumulate. Physical dependence can develop even when you take them exactly as prescribed, and withdrawal symptoms can be severe. Because of the dependence risk, sedation, and higher mortality associated with long-term use, clinical guidelines specifically recommend against benzodiazepines as a first-line or long-term treatment. Prescribers who do use them typically limit them to short-term, as-needed situations while waiting for an SSRI or SNRI to take effect.
Buspirone: A Non-Addictive Alternative
Buspirone is approved for generalized anxiety disorder and works through a different brain pathway than SSRIs, SNRIs, or benzodiazepines. Its main advantage is that it carries no risk of physical dependence and causes minimal sedation. It also doesn’t typically cause the sexual side effects or weight gain associated with SSRIs.
The trade-off is potency. Clinical evidence shows buspirone has a relatively modest effect size compared to other options. There’s no conclusive evidence that it works better than SSRIs, SNRIs, or benzodiazepines, and some studies found certain benzodiazepines were clearly more effective. One interesting finding: patients who had recently taken benzodiazepines tended to respond less well to buspirone, possibly because the faster, stronger effect of benzodiazepines made buspirone feel inadequate by comparison. For people with mild to moderate anxiety who want to avoid the side effects of SSRIs, buspirone can still be a reasonable choice.
Beta-Blockers for Situational Anxiety
If your anxiety is tied to specific situations, like public speaking, presentations, or performances, a beta-blocker like propranolol targets the physical symptoms rather than the mental ones. It blocks the adrenaline response that causes a racing heart, sweating, and trembling. A typical dose for situational anxiety is around 40 mg taken before the triggering event.
Beta-blockers don’t treat generalized or ongoing anxiety. They won’t quiet racing thoughts or reduce chronic worry. But for people whose anxiety is mainly triggered by predictable situations, and whose biggest problem is the physical symptoms that spiral into more anxiety, they can be remarkably effective without any of the long-term side effects or dependence risks of other options.
When the First Medication Doesn’t Work
Not everyone responds to the first anxiety medication they try. When an SSRI or SNRI at an adequate dose for an adequate length of time doesn’t provide enough relief, prescribers typically try one of several strategies: switching to a different SSRI or SNRI, adding a second medication on top of the first, or combining medication with cognitive behavioral therapy (CBT).
Augmentation options that have been studied include adding a low-dose antipsychotic, a benzodiazepine like clonazepam, or a medication originally designed for nerve pain called pregabalin. None of these are specifically approved for treatment-resistant anxiety, and the evidence base is limited. One consistent finding in the research is that borrowing strategies from treatment-resistant depression doesn’t reliably translate to better outcomes for anxiety. CBT, when added to medication, has some of the strongest support for people who haven’t responded to drugs alone.
It’s also worth knowing that the landscape of anxiety medications hasn’t changed much in recent years. Over the past 16 years, the FDA has approved only two new anxiety medications, both of which were reformulated versions of existing drugs rather than genuinely new treatments. This means the core options available today are largely the same ones that have been used for decades, and the differences between them come down to individual fit rather than one being objectively superior.
Anxiety Medication During Pregnancy
For people who are pregnant or planning to become pregnant, SSRIs have the strongest safety record. The American College of Obstetricians and Gynecologists has stated that robust evidence shows SSRIs are safe in pregnancy and that most do not increase the risk of birth defects. They’ve also emphasized that stopping SSRIs because of pregnancy can itself carry risks, including worsening anxiety or depression that affects both the parent and the developing baby. Benzodiazepines, by contrast, carry more concern during pregnancy due to potential effects on the newborn.